{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:42Z","timestamp":1781650722089,"version":"3.54.5"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11894-025-01001-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:42:52Z","timestamp":1752140572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fecal Microbiota Transplantation for Disorders of Gut-Brain Interaction: Current Insights, Effectiveness, and Future Perspectives"],"prefix":"10.1007","volume":"27","author":[{"given":"Taha Bin","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Damianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad-Ur-","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimra","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"1001_CR1","doi-asserted-by":"publisher","unstructured":"Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. Published Online Febr. 2016;18. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","DOI":"10.1053\/j.gastro.2016.02.031"},{"issue":"10263","key":"1001_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","volume":"396","author":"CJ Black","year":"2020","unstructured":"Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional Gastrointestinal disorders: advances in Understanding and management. Lancet. 2020;396(10263):1664\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)32115-2.","journal-title":"Lancet"},{"issue":"5","key":"1001_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S2468-1253(20)30363-0","volume":"6","author":"HM Staudacher","year":"2021","unstructured":"Staudacher HM, Mikocka-Walus A, Ford AC. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. Lancet Gastroenterol Hepatol. 2021;6(5):401\u201310. https:\/\/doi.org\/10.1016\/S2468-1253(20)30363-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1001_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional Gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99\u2013e1143. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.014.","journal-title":"Gastroenterology"},{"issue":"1","key":"1001_CR5","doi-asserted-by":"publisher","first-page":"G52","DOI":"10.1152\/ajpgi.00338.2016","volume":"312","author":"Y Bhattarai","year":"2017","unstructured":"Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312(1):G52\u201362. https:\/\/doi.org\/10.1152\/ajpgi.00338.2016.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1001_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17\u201344. https:\/\/doi.org\/10.14309\/ajg.0000000000001036.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1001_CR7","doi-asserted-by":"publisher","first-page":"e19107","DOI":"10.1097\/MD.0000000000019107","volume":"99","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu HM, Wang X, et al. Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis. Med (Baltim). 2020;99(7):e19107. https:\/\/doi.org\/10.1097\/MD.0000000000019107.","journal-title":"Med (Baltim)"},{"key":"1001_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","volume":"113","author":"J Dionne","year":"2018","unstructured":"Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low fodmaps diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol. 2018;113:1290\u2013300. https:\/\/doi.org\/10.1038\/s41395-018-0195-4.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1001_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/apt.17791","volume":"59","author":"HM Staudacher","year":"2024","unstructured":"Staudacher HM, Mahoney S, Canale K, et al. Clinical trial: A mediterranean diet is feasible and improves Gastrointestinal and psychological symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2024;59(4):492\u2013503. https:\/\/doi.org\/10.1111\/apt.17791.","journal-title":"Aliment Pharmacol Ther"},{"key":"1001_CR10","doi-asserted-by":"publisher","unstructured":"Lei Y, Sun X, Ruan T, et al. Effects of probiotics and diet management in patients with irritable bowel syndrome: A systematic review and network Meta-analysis. Nutr Rev Published Online January. 2025;25. https:\/\/doi.org\/10.1093\/nutrit\/nuae217.","DOI":"10.1093\/nutrit\/nuae217"},{"key":"1001_CR11","doi-asserted-by":"publisher","first-page":"175628481989753","DOI":"10.1177\/1756284819897531","volume":"13","author":"WD Chey","year":"2020","unstructured":"Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Th Adv Gastroenterol. 2020;13:1756284819897531. https:\/\/doi.org\/10.1177\/1756284819897531. Published 2020 Jan 23.","journal-title":"Th Adv Gastroenterol"},{"issue":"9","key":"1001_CR12","doi-asserted-by":"publisher","first-page":"e44807","DOI":"10.7759\/cureus.44807","volume":"15","author":"Z Khan","year":"2023","unstructured":"Khan Z, Khan SK, Reyaz I, et al. Effectiveness of rifaximin on the outcomes of irritable bowel syndrome: A systematic review and Meta-Analysis of randomized controlled trials. Cureus. 2023;15(9):e44807. https:\/\/doi.org\/10.7759\/cureus.44807. Published 2023 Sep 6.","journal-title":"Cureus"},{"issue":"5","key":"1001_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/gutjnl-2019-320411","volume":"69","author":"G Barbara","year":"2020","unstructured":"Barbara G, Ianiro G. Faecal microbial transplantation in IBS: ready for prime time? Gut. 2020;69(5):795\u20136. https:\/\/doi.org\/10.1136\/gutjnl-2019-320411.","journal-title":"Gut"},{"issue":"5717","key":"1001_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F B\u00e4ckhed","year":"2005","unstructured":"B\u00e4ckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915\u201320. https:\/\/doi.org\/10.1126\/science.1104816.","journal-title":"Science"},{"issue":"8","key":"1001_CR15","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and Bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. https:\/\/doi.org\/10.1371\/journal.pbio.1002533. Published 2016 Aug 19.","journal-title":"PLoS Biol"},{"issue":"1","key":"1001_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2016.02.001","volume":"30","author":"C Chang","year":"2016","unstructured":"Chang C, Lin H. Dysbiosis in Gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2016;30(1):3\u201315. https:\/\/doi.org\/10.1016\/j.bpg.2016.02.001.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"1001_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1128\/am.27.5.961-979.1974","volume":"27","author":"WE Moore","year":"1974","unstructured":"Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol. 1974;27(5):961\u201379. https:\/\/doi.org\/10.1128\/am.27.5.961-979.1974.","journal-title":"Appl Microbiol"},{"issue":"4","key":"1001_CR18","doi-asserted-by":"publisher","first-page":"e93827","DOI":"10.1371\/journal.pone.0093827","volume":"9","author":"R Poretsky","year":"2014","unstructured":"Poretsky R, Rodriguez-R LM, Luo C, Tsementzi D, Konstantinidis KT. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing Temporal microbial community dynamics. PLoS ONE. 2014;9(4):e93827. https:\/\/doi.org\/10.1371\/journal.pone.0093827. Published 2014 Apr 8.","journal-title":"PLoS ONE"},{"issue":"4","key":"1001_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00335-021-09889-x","volume":"32","author":"S Yen","year":"2021","unstructured":"Yen S, Johnson JS. Metagenomics: a path to Understanding the gut Microbiome. Mamm Genome. 2021;32(4):282\u201396. https:\/\/doi.org\/10.1007\/s00335-021-09889-x.","journal-title":"Mamm Genome"},{"issue":"10","key":"1001_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(15)00293-5","volume":"15","author":"P Hugon","year":"2015","unstructured":"Hugon P, Dufour JC, Colson P, Fournier PE, Sallah K, Raoult D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis. 2015;15(10):1211\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(15)00293-5.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1001_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4. Published 2022 Apr 23.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"1001_CR22","doi-asserted-by":"publisher","first-page":"e1001424","DOI":"10.1371\/journal.pbio.1001424","volume":"10","author":"J Schluter","year":"2012","unstructured":"Schluter J, Foster KR. The evolution of mutualism in gut microbiota via host epithelial selection. PLoS Biol. 2012;10(11):e1001424. https:\/\/doi.org\/10.1371\/journal.pbio.1001424.","journal-title":"PLoS Biol"},{"issue":"6","key":"1001_CR23","doi-asserted-by":"publisher","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","volume":"8","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE. 2013;8(6):e66019. https:\/\/doi.org\/10.1371\/journal.pone.0066019. Published 2013 Jun 17.","journal-title":"PLoS ONE"},{"issue":"8","key":"1001_CR24","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms21082668","volume":"21","author":"M Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 M, Me\u0161trovi\u0107 T, Paljetak H\u010c, Peri\u0107 M, Bare\u0161i\u0107 A, Verbanac D. Gut microbiota beyond Bacteria-Mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020;21(8):2668. https:\/\/doi.org\/10.3390\/ijms21082668. Published 2020 Apr 11.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1001_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/aem.43.1.227-232.1982","volume":"43","author":"TL Miller","year":"1982","unstructured":"Miller TL, Wolin MJ, Conway de Macario E, Macario AJ. Isolation of Methanobrevibacter smithii from human feces. Appl Environ Microbiol. 1982;43(1):227\u201332. https:\/\/doi.org\/10.1128\/aem.43.1.227-232.1982.","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"1001_CR26","doi-asserted-by":"publisher","first-page":"e969","DOI":"10.1016\/S2666-5247(22)00203-8","volume":"3","author":"F Zhang","year":"2022","unstructured":"Zhang F, Aschenbrenner D, Yoo JY, Zuo T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial Microbiome assembly. Lancet Microbe. 2022;3(12):e969\u201383. https:\/\/doi.org\/10.1016\/S2666-5247(22)00203-8.","journal-title":"Lancet Microbe"},{"key":"1001_CR27","doi-asserted-by":"publisher","unstructured":"Perez-Mu\u00f1oz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the sterile womb and in utero colonization hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5(1):48. Published 2017 Apr 28. https:\/\/doi.org\/10.1186\/s40168-017-0268-4","DOI":"10.1186\/s40168-017-0268-4"},{"key":"1001_CR28","doi-asserted-by":"publisher","first-page":"26050","DOI":"10.3402\/mehd.v26.26050","volume":"26","author":"JM Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez JM, Murphy K, Stanton C, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015;26:26050. https:\/\/doi.org\/10.3402\/mehd.v26.26050. Published 2015 Feb 2.","journal-title":"Microb Ecol Health Dis"},{"issue":"1","key":"1001_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/1574-6941.12223","volume":"87","author":"E Avershina","year":"2014","unstructured":"Avershina E, Storr\u00f8 O, \u00d8ien T, Johnsen R, Pope P, Rudi K. Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol Ecol. 2014;87(1):280\u201390. https:\/\/doi.org\/10.1111\/1574-6941.12223.","journal-title":"FEMS Microbiol Ecol"},{"issue":"4","key":"1001_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/gutjnl-2012-303249","volume":"63","author":"HE Jakobsson","year":"2014","unstructured":"Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63(4):559\u201366. https:\/\/doi.org\/10.1136\/gutjnl-2012-303249.","journal-title":"Gut"},{"issue":"17","key":"1001_CR31","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.3390\/nu14173554","volume":"14","author":"HY Chong","year":"2022","unstructured":"Chong HY, Tan LT, Law JW, et al. Exploring the potential of human milk and formula milk on infants\u2019 gut and health. Nutrients. 2022;14(17):3554. https:\/\/doi.org\/10.3390\/nu14173554. Published 2022 Aug 29.","journal-title":"Nutrients"},{"issue":"1Suppl 1","key":"1001_CR32","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1073\/pnas.1000097107","volume":"108","author":"MJ Claesson","year":"2011","unstructured":"Claesson MJ, Cusack S, O\u2019Sullivan O, et al. Composition, variability, and Temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108(1Suppl 1):4586\u201391. https:\/\/doi.org\/10.1073\/pnas.1000097107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1001_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2012.10.005","volume":"69","author":"E Biagi","year":"2013","unstructured":"Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res. 2013;69(1):11\u201320. https:\/\/doi.org\/10.1016\/j.phrs.2012.10.005.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1001_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri2710","volume":"10","author":"LV Hooper","year":"2010","unstructured":"Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10(3):159\u201369. https:\/\/doi.org\/10.1038\/nri2710.","journal-title":"Nat Rev Immunol"},{"issue":"7484","key":"1001_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut Microbiome. Nature. 2014;505(7484):559\u201363. https:\/\/doi.org\/10.1038\/nature12820.","journal-title":"Nature"},{"issue":"2","key":"1001_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/glycob\/cws138","volume":"23","author":"ZT Yu","year":"2013","unstructured":"Yu ZT, Chen C, Kling DE, et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 2013;23(2):169\u201377. https:\/\/doi.org\/10.1093\/glycob\/cws138.","journal-title":"Glycobiology"},{"issue":"16","key":"1001_CR37","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1016\/j.jmb.2016.02.010","volume":"428","author":"L Arike","year":"2016","unstructured":"Arike L, Hansson GC. The densely O-Glycosylated MUC2 mucin protects the intestine and provides food for the commensal Bacteria. J Mol Biol. 2016;428(16):3221\u20139. https:\/\/doi.org\/10.1016\/j.jmb.2016.02.010.","journal-title":"J Mol Biol"},{"key":"1001_CR38","doi-asserted-by":"publisher","unstructured":"Damianos J, Abdelnaem N, Camilleri M, Gut Goo. Physiology, diet, and therapy of intestinal mucus and biofilms in Gastrointestinal health and disease. Clin Gastroenterol Hepatol. 2025;23(2):205\u201315. https:\/\/doi.org\/10.1016\/j.cgh.2024.09.007.","DOI":"10.1016\/j.cgh.2024.09.007"},{"key":"1001_CR39","doi-asserted-by":"publisher","unstructured":"Tailford LE, Owen CD, Walshaw J et al. Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat Commun. 2015;6:7624. Published 2015 Jul 8. https:\/\/doi.org\/10.1038\/ncomms8624","DOI":"10.1038\/ncomms8624"},{"issue":"3","key":"1001_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","volume":"30","author":"JM Ridlon","year":"2014","unstructured":"Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut Microbiome. Curr Opin Gastroenterol. 2014;30(3):332\u20138. https:\/\/doi.org\/10.1097\/MOG.0000000000000057.","journal-title":"Curr Opin Gastroenterol"},{"issue":"5790","key":"1001_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1126\/science.1127119","volume":"313","author":"HL Cash","year":"2006","unstructured":"Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313(5790):1126\u201330. https:\/\/doi.org\/10.1126\/science.1127119.","journal-title":"Science"},{"issue":"7","key":"1001_CR42","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1128\/iai.64.7.2794-2798.1996","volume":"64","author":"V Friman","year":"1996","unstructured":"Friman V, Adlerberth I, Connell H, Svanborg C, Hanson LA, Wold AE. Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of Immunoglobulin A-deficient individuals. Infect Immun. 1996;64(7):2794\u20138. https:\/\/doi.org\/10.1128\/iai.64.7.2794-2798.1996.","journal-title":"Infect Immun"},{"issue":"3","key":"1001_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.it.2016.11.008","volume":"38","author":"RM Berbers","year":"2017","unstructured":"Berbers RM, Nierkens S, van Laar JM, Bogaert D, Leavis HL. Microbial dysbiosis in common variable immune deficiencies: evidence, causes, and consequences. Trends Immunol. 2017;38(3):206\u201316. https:\/\/doi.org\/10.1016\/j.it.2016.11.008.","journal-title":"Trends Immunol"},{"key":"1001_CR44","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1038\/ncomms3469","volume":"4","author":"AV Tyakht","year":"2013","unstructured":"Tyakht AV, Kostryukova ES, Popenko AS, et al. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun. 2013;4:2469. https:\/\/doi.org\/10.1038\/ncomms3469.","journal-title":"Nat Commun"},{"issue":"4","key":"1001_CR45","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/advances\/nmaa016","volume":"11","author":"TLK Bear","year":"2020","unstructured":"Bear TLK, Dalziel JE, Coad J, Roy NC, Butts CA, Gopal PK. The role of the gut microbiota in dietary interventions for depression and anxiety. Adv Nutr. 2020;11(4):890\u2013907. https:\/\/doi.org\/10.1093\/advances\/nmaa016.","journal-title":"Adv Nutr"},{"issue":"4","key":"1001_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/ph16040565","volume":"16","author":"A Kumar","year":"2023","unstructured":"Kumar A, Pramanik J, Goyal N, et al. Gut microbiota in anxiety and depression: unveiling the relationships and management options. Pharmaceuticals (Basel). 2023;16(4):565. https:\/\/doi.org\/10.3390\/ph16040565. Published 2023 Apr 9.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1001_CR47","doi-asserted-by":"publisher","first-page":"104527","DOI":"10.1016\/j.ebiom.2023.104527","volume":"90","author":"L Liu","year":"2023","unstructured":"Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90:104527. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104527.","journal-title":"EBioMedicine"},{"issue":"1","key":"1001_CR48","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1038\/s41467-022-34502-3","volume":"13","author":"D Radjabzadeh","year":"2022","unstructured":"Radjabzadeh D, Bosch JA, Uitterlinden AG, et al. Gut microbiome-wide association study of depressive symptoms. Nat Commun. 2022;13(1):7128. https:\/\/doi.org\/10.1038\/s41467-022-34502-3. Published 2022 Dec 6.","journal-title":"Nat Commun"},{"issue":"1","key":"1001_CR49","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","volume":"108","author":"L Dethlefsen","year":"2011","unstructured":"Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108(1):4554\u201361. https:\/\/doi.org\/10.1073\/pnas.1000087107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1001_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4161\/gmic.27128","volume":"5","author":"M Ferrer","year":"2014","unstructured":"Ferrer M, Martins dos Santos VA, Ott SJ, Moya A. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes. 2014;5(1):64\u201370. https:\/\/doi.org\/10.4161\/gmic.27128.","journal-title":"Gut Microbes"},{"issue":"7469","key":"1001_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature12503","volume":"502","author":"KM Ng","year":"2013","unstructured":"Ng KM, Ferreyra JA, Higginbottom SK, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502(7469):96\u20139. https:\/\/doi.org\/10.1038\/nature12503.","journal-title":"Nature"},{"key":"1001_CR52","doi-asserted-by":"publisher","first-page":"1110787","DOI":"10.3389\/fcimb.2023.1110787","volume":"13","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Hu Y, Tang J, Xu W, Zhu W, Zhang W. The implication of gut microbiota in recovery from Gastrointestinal surgery. Front Cell Infect Microbiol. 2023;13:1110787. https:\/\/doi.org\/10.3389\/fcimb.2023.1110787. Published 2023 Feb 28.","journal-title":"Front Cell Infect Microbiol"},{"issue":"29","key":"1001_CR53","doi-asserted-by":"publisher","first-page":"e29826","DOI":"10.1097\/MD.0000000000029826","volume":"101","author":"Y Shi","year":"2022","unstructured":"Shi Y, Cui H, Wang F, et al. Role of gut microbiota in postoperative complications and prognosis of Gastrointestinal surgery: A narrative review. Med (Baltim). 2022;101(29):e29826. https:\/\/doi.org\/10.1097\/MD.0000000000029826. Published 2022 Jul 22.","journal-title":"Med (Baltim)"},{"issue":"3","key":"1001_CR54","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132(3):913\u201320. https:\/\/doi.org\/10.1053\/j.gastro.2007.01.046.","journal-title":"Gastroenterology"},{"issue":"1","key":"1001_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2018.07.011","volume":"156","author":"G Barbara","year":"2019","unstructured":"Barbara G, Grover M, Bercik P, et al. Rome foundation working team report on Post-Infection irritable bowel syndrome. Gastroenterology. 2019;156(1):46\u2013e587. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.011.","journal-title":"Gastroenterology"},{"issue":"4","key":"1001_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2036.2007.03399.x","volume":"26","author":"M Thabane","year":"2007","unstructured":"Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26(4):535\u201344. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03399.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1001_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel Syndrome-A systematic review. Gastroenterology. 2019;157(1):97\u2013108. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.049.","journal-title":"Gastroenterology"},{"issue":"4","key":"1001_CR58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","volume":"158","author":"IB Jeffery","year":"2020","unstructured":"Jeffery IB, Das A, O\u2019Herlihy E, et al. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterology. 2020;158(4):1016\u2013e10288. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.301.","journal-title":"Gastroenterology"},{"issue":"2","key":"1001_CR59","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.14309\/ctg.0000000000000012","volume":"10","author":"R Duan","year":"2019","unstructured":"Duan R, Zhu S, Wang B, Duan L. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-Targeted sequencing: A systematic review. Clin Transl Gastroenterol. 2019;10(2):e00012. https:\/\/doi.org\/10.14309\/ctg.0000000000000012.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"1001_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap J, Derrien M, T\u00f6rnblom H, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152(1):111\u2013e1238. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.049.","journal-title":"Gastroenterology"},{"issue":"6","key":"1001_CR61","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","volume":"310","author":"T Ringel-Kulka","year":"2016","unstructured":"Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol. 2016;310(6):G417\u201326. https:\/\/doi.org\/10.1152\/ajpgi.00044.2015.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1001_CR62","doi-asserted-by":"publisher","unstructured":"Jacobs JP, Lagishetty V, Hauer MC et al. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome. 2023;11(1):5. Published 2023 Jan 10. https:\/\/doi.org\/10.1186\/s40168-022-01450-5","DOI":"10.1186\/s40168-022-01450-5"},{"key":"1001_CR63","doi-asserted-by":"publisher","first-page":"910568","DOI":"10.3389\/fphys.2022.910568","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Zeng Y, Zhang H, Ma Y. The role of Gastrointestinal microbiota in functional dyspepsia: A review. Front Physiol. 2022;13:910568. https:\/\/doi.org\/10.3389\/fphys.2022.910568. Published 2022 Jun 8.","journal-title":"Front Physiol"},{"issue":"3","key":"1001_CR64","doi-asserted-by":"publisher","first-page":"G368","DOI":"10.1152\/ajpgi.2001.280.3.G368","volume":"280","author":"E Husebye","year":"2001","unstructured":"Husebye E, Hellstr\u00f6m PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol. 2001;280(3):G368\u201380. https:\/\/doi.org\/10.1152\/ajpgi.2001.280.3.G368.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5505","key":"1001_CR65","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.291.5505.881","volume":"291","author":"LV Hooper","year":"2001","unstructured":"Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881\u20134. https:\/\/doi.org\/10.1126\/science.291.5505.881.","journal-title":"Science"},{"issue":"1","key":"1001_CR66","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1038\/s41598-017-10663-w","volume":"7","author":"L Mancabelli","year":"2017","unstructured":"Mancabelli L, Milani C, Lugli GA, et al. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Sci Rep. 2017;7(1):9879. https:\/\/doi.org\/10.1038\/s41598-017-10663-w. Published 2017 Aug 29.","journal-title":"Sci Rep"},{"issue":"5","key":"1001_CR67","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/gastro\/goab035","volume":"9","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang R, Li D, Zhao L, Zhu L. Role of gut microbiota in functional constipation. Gastroenterol Rep (Oxf). 2021;9(5):392\u2013401. https:\/\/doi.org\/10.1093\/gastro\/goab035. Published 2021 Aug 6.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"1001_CR68","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/microorganisms10030578","volume":"10","author":"T Hrncir","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3):578. https:\/\/doi.org\/10.3390\/microorganisms10030578. Published 2022 Mar 7.","journal-title":"Microorganisms"},{"issue":"3","key":"1001_CR69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","volume":"1","author":"C Llorente","year":"2015","unstructured":"Llorente C, Schnabl B. The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol. 2015;1(3):275\u201384. https:\/\/doi.org\/10.1016\/j.jcmgh.2015.04.003.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"1001_CR70","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/ajg.2010.281","volume":"105","author":"CW Png","year":"2010","unstructured":"Png CW, Lind\u00e9n SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420\u20138. https:\/\/doi.org\/10.1038\/ajg.2010.281.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1001_CR71","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","volume":"68","author":"H Chu","year":"2019","unstructured":"Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68(2):359\u201370. https:\/\/doi.org\/10.1136\/gutjnl-2018-316307.","journal-title":"Gut"},{"issue":"5","key":"1001_CR72","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","volume":"145","author":"LP Smits","year":"2013","unstructured":"Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145(5):946\u201353. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.058.","journal-title":"Gastroenterology"},{"issue":"11","key":"1001_CR73","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/ajg.2012.251","volume":"107","author":"F Zhang","year":"2012","unstructured":"Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107(11):1755\u2013p. https:\/\/doi.org\/10.1038\/ajg.2012.251.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1001_CR74","first-page":"854","volume":"44","author":"B EISEMAN","year":"1958","unstructured":"EISEMAN B, SILEN W, BASCOM GS, KAUVAR AJ. Fecal enema as an adjunct in the treatment of pseudomembranous Enterocolitis. Surgery. 1958;44(5):854\u20139.","journal-title":"Surgery"},{"issue":"2","key":"1001_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","volume":"92","author":"M Baxter","year":"2016","unstructured":"Baxter M, Colville A. Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect. 2016;92(2):117\u201327. https:\/\/doi.org\/10.1016\/j.jhin.2015.10.024.","journal-title":"J Hosp Infect"},{"key":"1001_CR76","doi-asserted-by":"publisher","unstructured":"Shogbesan O, Poudel DR, Victor S et al. A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients. Can J Gastroenterol Hepatol. 2018;2018:1394379. Published 2018 Sep 2. https:\/\/doi.org\/10.1155\/2018\/1394379","DOI":"10.1155\/2018\/1394379"},{"issue":"21","key":"1001_CR77","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1056\/NEJMc1913670","volume":"381","author":"Z Kassam","year":"2019","unstructured":"Kassam Z, Dubois N, Ramakrishna B, et al. Donor screening for fecal microbiota transplantation. N Engl J Med. 2019;381(21):2070\u20132. https:\/\/doi.org\/10.1056\/NEJMc1913670.","journal-title":"N Engl J Med"},{"issue":"6","key":"1001_CR78","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/19490976.2018.1458179","volume":"9","author":"SMD J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen SMD, Erikstrup C, Dinh KM, Lemming LE, Dahlerup JF, Hvas CL. Recruitment of feces donors among blood donors: results from an observational cohort study. Gut Microbes. 2018;9(6):540\u201350. https:\/\/doi.org\/10.1080\/19490976.2018.1458179.","journal-title":"Gut Microbes"},{"issue":"21","key":"1001_CR79","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1910437.","journal-title":"N Engl J Med"},{"key":"1001_CR80","unstructured":"US Food and Drug Administration. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. Paris: FAO; 2019 Jun. p. 13."},{"key":"1001_CR81","unstructured":"US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. Food and Drug Administration: Silver Spring, MD. 2020 Mar 12."},{"issue":"1","key":"1001_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","volume":"159","author":"KS Cheung","year":"2020","unstructured":"Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and Meta-analysis. Gastroenterology. 2020;159(1):81\u201395. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.065.","journal-title":"Gastroenterology"},{"key":"1001_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2019.04.008","volume":"49","author":"FE Dailey","year":"2019","unstructured":"Dailey FE, Turse EP, Daglilar E, Tahan V. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr Opin Pharmacol. 2019;49:29\u201333. https:\/\/doi.org\/10.1016\/j.coph.2019.04.008.","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"1001_CR84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.15403\/jgld.2014.1121.253.cel","volume":"25","author":"YH van Beurden","year":"2016","unstructured":"van Beurden YH, van Gils T, van Gils NA, Kassam Z, Mulder CJ, Aparicio-Pag\u00e9s N. Serendipity in refractory Celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer. J Gastrointestin Liver Dis. 2016;25(3):385\u20138. https:\/\/doi.org\/10.15403\/jgld.2014.1121.253.cel.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"19","key":"1001_CR85","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.12998\/wjcc.v7.i19.3074","volume":"7","author":"WR Xie","year":"2019","unstructured":"Xie WR, Yang XY, Xia HH, Wu LH, He XX. Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: A case report and review of the literature. World J Clin Cases. 2019;7(19):3074\u201381. https:\/\/doi.org\/10.12998\/wjcc.v7.i19.3074.","journal-title":"World J Clin Cases"},{"issue":"1","key":"1001_CR86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simr\u00e9n","year":"2013","unstructured":"Simr\u00e9n M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159\u201376. https:\/\/doi.org\/10.1136\/gutjnl-2012-302167.","journal-title":"Gut"},{"issue":"11","key":"1001_CR87","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3109\/00365520903274401","volume":"44","author":"MH Morken","year":"2009","unstructured":"Morken MH, Valeur J, Norin E, Midtvedt T, Nysaeter G, Berstad A. Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J Gastroenterol. 2009;44(11):1296\u2013303. https:\/\/doi.org\/10.3109\/00365520903274401.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"1001_CR88","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/ajg.2014.295","volume":"109","author":"DM Pinn","year":"2014","unstructured":"Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation the answer for irritable bowel syndrome? A single-center experience. Am J Gastroenterol. 2014;109(11):1831\u20132. https:\/\/doi.org\/10.1038\/ajg.2014.295.","journal-title":"Am J Gastroenterol"},{"key":"1001_CR89","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/nmo.12612","volume":"27","author":"R Cruz-Aguilar","year":"2015","unstructured":"Cruz-Aguilar R, Buch T, Bajbouj M, et al. Fecal microbiota transplantation as a novel therapy for irritable bowel syndrome with predominant diarrhea. Neurogastroenterol Motil. 2015;27:110\u2013110.","journal-title":"Neurogastroenterol Motil"},{"key":"1001_CR90","unstructured":"Hong J, Bang B, Shin Y et al. Treatment of irritable bowel syndrome with fecal microbiota transplantation: a case series of 10 patients. United European Gastroenterol J. 2016; 4."},{"key":"1001_CR91","first-page":"A294","volume":"4","author":"G Syzenko","year":"2016","unstructured":"Syzenko G, Budovska L, Puchkov K. Efficiency of FMT in cases of treatment-resistant IBS. United Eur Gastroenterol J. 2016;4:A294\u2013294.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"1001_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000471919","volume":"96","author":"S Mizuno","year":"2017","unstructured":"Mizuno S, Masaoka T, Naganuma M, et al. Bifidobacterium-Rich fecal donor May be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion. 2017;96(1):29\u201338. https:\/\/doi.org\/10.1159\/000471919.","journal-title":"Digestion"},{"issue":"5","key":"1001_CR93","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/gutjnl-2016-312513","volume":"66","author":"T Holvoet","year":"2017","unstructured":"Holvoet T, Joossens M, Wang J, et al. Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating. Gut. 2017;66(5):980\u20132. https:\/\/doi.org\/10.1136\/gutjnl-2016-312513.","journal-title":"Gut"},{"key":"1001_CR94","doi-asserted-by":"crossref","first-page":"A677","DOI":"10.1177\/2050640616637968","volume":"4","author":"T Mazzawi","year":"2016","unstructured":"Mazzawi T, Lied GA, El-Salhy M, et al. Effect of faecal microbiota transplantation on the symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. United Eur Gastroenterol J. 2016;4:A677\u2013677.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"1001_CR95","doi-asserted-by":"publisher","first-page":"e00034","DOI":"10.14309\/ctg.0000000000000034","volume":"10","author":"S Holster","year":"2019","unstructured":"Holster S, Lindqvist CM, Repsilber D, et al. The effect of allogenic versus autologous fecal microbiota transfer on symptoms, visceral perception and fecal and mucosal microbiota in irritable bowel syndrome: A randomized controlled study. Clin Transl Gastroenterol. 2019;10(4):e00034. https:\/\/doi.org\/10.14309\/ctg.0000000000000034.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"1001_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","volume":"3","author":"PH Johnsen","year":"2018","unstructured":"Johnsen PH, Hilp\u00fcsch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17\u201324. https:\/\/doi.org\/10.1016\/S2468-1253(17)30338-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"1001_CR97","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S2468-1253(19)30198-0","volume":"4","author":"OC Aroniadis","year":"2019","unstructured":"Aroniadis OC, Brandt LJ, Oneto C, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4(9):675\u201385. https:\/\/doi.org\/10.1016\/S2468-1253(19)30198-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"1001_CR98","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","volume":"67","author":"SI Halkj\u00e6r","year":"2018","unstructured":"Halkj\u00e6r SI, Christensen AH, Lo BZS, et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018;67(12):2107\u201315. https:\/\/doi.org\/10.1136\/gutjnl-2018-316434.","journal-title":"Gut"},{"issue":"1","key":"1001_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","volume":"160","author":"T Holvoet","year":"2021","unstructured":"Holvoet T, Joossens M, V\u00e1zquez-Castellanos JF, et al. Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: Short- and Long-term results from a Placebo-Controlled randomized trial. Gastroenterology. 2021;160(1):145\u2013e1578. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.013.","journal-title":"Gastroenterology"},{"issue":"12","key":"1001_CR100","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/apt.15740","volume":"51","author":"P Lahtinen","year":"2020","unstructured":"Lahtinen P, Jalanka J, Hartikainen A, et al. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Aliment Pharmacol Ther. 2020;51(12):1321\u201331. https:\/\/doi.org\/10.1111\/apt.15740.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1001_CR101","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","volume":"69","author":"M El-Salhy","year":"2020","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, Br\u00e5then Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859\u201367. https:\/\/doi.org\/10.1136\/gutjnl-2019-319630.","journal-title":"Gut"},{"issue":"1","key":"1001_CR102","doi-asserted-by":"publisher","first-page":"2020067","DOI":"10.1080\/19490976.2021.2020067","volume":"14","author":"P Singh","year":"2022","unstructured":"Singh P, Alm EJ, Kelley JM, et al. Effect of antibiotic pretreatment on bacterial engraftment after fecal microbiota transplant (FMT) in IBS-D. Gut Microbes. 2022;14(1):2020067. https:\/\/doi.org\/10.1080\/19490976.2021.2020067.","journal-title":"Gut Microbes"},{"issue":"1","key":"1001_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41522-024-00549-x","volume":"10","author":"AK Hartikainen","year":"2024","unstructured":"Hartikainen AK, Jalanka J, Lahtinen P, et al. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients. NPJ Biofilms Microbiomes. 2024;10(1):73. https:\/\/doi.org\/10.1038\/s41522-024-00549-x. Published 2024 Aug 28.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"1001_CR104","doi-asserted-by":"publisher","first-page":"11885","DOI":"10.1080\/21655979.2021.1999374","volume":"12","author":"Q Guo","year":"2021","unstructured":"Guo Q, Lin H, Chen P, et al. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of Enterobacteria capsules. Bioengineered. 2021;12(2):11885\u201397. https:\/\/doi.org\/10.1080\/21655979.2021.1999374.","journal-title":"Bioengineered"},{"issue":"7","key":"1001_CR105","doi-asserted-by":"publisher","first-page":"S936","DOI":"10.1016\/S0016-5085(22)62221-2","volume":"162","author":"N Aumpan","year":"2022","unstructured":"Aumpan N, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, et al. Effect of fecal microbiota transplantation (FMT) on irritable bowel syndrome (IBS): a randomized, placebo-controlled, double-blind study. Gastroenterology. 2022;162(7):S936\u20137.","journal-title":"Gastroenterology"},{"issue":"9","key":"1001_CR106","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/microorganisms10091819","volume":"10","author":"T Mazzawi","year":"2022","unstructured":"Mazzawi T, Hausken T, Refsnes PF, Hatlebakk JG, Lied GA. The effect of anaerobically cultivated human intestinal microbiota compared to fecal microbiota transplantation on gut microbiota profile and symptoms of irritable bowel syndrome, a Double-Blind Placebo-Controlled study. Microorganisms. 2022;10(9):1819. https:\/\/doi.org\/10.3390\/microorganisms10091819. Published 2022 Sep 11.","journal-title":"Microorganisms"},{"issue":"8","key":"1001_CR107","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/apt.17703","volume":"58","author":"YK Yau","year":"2023","unstructured":"Yau YK, Su Q, Xu Z, et al. Randomised clinical trial: faecal microbiota transplantation for irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2023;58(8):795\u2013804. https:\/\/doi.org\/10.1111\/apt.17703.","journal-title":"Aliment Pharmacol Ther"},{"key":"1001_CR108","doi-asserted-by":"publisher","first-page":"102562","DOI":"10.1016\/j.ebiom.2019.11.023","volume":"51","author":"PH Johnsen","year":"2020","unstructured":"Johnsen PH, Hilp\u00fcsch F, Valle PC, Goll R. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: secondary endpoints of a double blind, randomized, placebo-controlled trial. EBioMedicine. 2020;51:102562. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.023.","journal-title":"EBioMedicine"},{"issue":"4","key":"1001_CR109","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.gastro.2022.06.020","volume":"163","author":"M El-Salhy","year":"2022","unstructured":"El-Salhy M, Winkel R, Casen C, Hausken T, Gilja OH, Hatlebakk JG. Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at 3 years after transplantation. Gastroenterology. 2022;163(4):982\u2013e99414. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.020.","journal-title":"Gastroenterology"},{"key":"1001_CR110","doi-asserted-by":"publisher","unstructured":"Cui J, Lin Z, Tian H, et al., et al. Long-Term Follow-Up results of fecal microbiota transplantation for irritable bowel syndrome: A Single-Center, retrospective study. Front Med (Lausanne). 2021;8:710452. https:\/\/doi.org\/10.3389\/fmed.2021.710452. Published 2021 Jul 30.","DOI":"10.3389\/fmed.2021.710452"},{"issue":"7","key":"1001_CR111","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/00365521.2021.1915375","volume":"56","author":"AMA Madsen","year":"2021","unstructured":"Madsen AMA, Halkj\u00e6r SI, Christensen AH, et al. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study. Scand J Gastroenterol. 2021;56(7):761\u20139. https:\/\/doi.org\/10.1080\/00365521.2021.1915375.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"1001_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1927635","volume":"13","author":"PD Browne","year":"2021","unstructured":"Browne PD, Cold F, Petersen AM, et al. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms. Gut Microbes. 2021;13(1):1\u201316. https:\/\/doi.org\/10.1080\/19490976.2021.1927635.","journal-title":"Gut Microbes"},{"issue":"1","key":"1001_CR113","doi-asserted-by":"publisher","first-page":"1794263","DOI":"10.1080\/19490976.2020.1794263","volume":"12","author":"R Goll","year":"2020","unstructured":"Goll R, Johnsen PH, Hjerde E, et al. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut Microbiome. Gut Microbes. 2020;12(1):1794263. https:\/\/doi.org\/10.1080\/19490976.2020.1794263.","journal-title":"Gut Microbes"},{"issue":"10","key":"1001_CR114","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/biom9100586","volume":"9","author":"S Holster","year":"2019","unstructured":"Holster S, Hooiveld GJ, Repsilber D, Vos WM, Brummer RJ, K\u00f6nig J. Allogenic faecal microbiota transfer induces Immune-Related gene sets in the Colon mucosa of patients with irritable bowel syndrome. Biomolecules. 2019;9(10):586. https:\/\/doi.org\/10.3390\/biom9100586. Published 2019 Oct 8.","journal-title":"Biomolecules"},{"issue":"6","key":"1001_CR115","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/nu11061415","volume":"11","author":"M El-Salhy","year":"2019","unstructured":"El-Salhy M, Hausken T, Hatlebakk JG. Increasing the dose and\/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS). Nutrients. 2019;11(6):1415. https:\/\/doi.org\/10.3390\/nu11061415. Published 2019 Jun 24.","journal-title":"Nutrients"},{"issue":"2","key":"1001_CR116","doi-asserted-by":"publisher","first-page":"e0171308","DOI":"10.1371\/journal.pone.0171308","volume":"12","author":"H Tian","year":"2017","unstructured":"Tian H, Ge X, Nie Y, et al. Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial. PLoS ONE. 2017;12(2):e0171308. https:\/\/doi.org\/10.1371\/journal.pone.0171308. Published 2017 Feb 3.","journal-title":"PLoS ONE"},{"key":"1001_CR117","first-page":"04","volume":"7","author":"QY Liu","year":"2017","unstructured":"Liu QY, Zhang S, Chao HC, et al. Effect of fecal microbial transplant on clinical outcomes and life quality in refractory functional constipation. Chin J Digest Med Imageol (Electronic Edition). 2017;7:04\u20138.","journal-title":"Chin J Digest Med Imageol (Electronic Edition)"},{"key":"1001_CR118","first-page":"2731","volume":"35","author":"SJ Dun","year":"2019","unstructured":"Dun SJ, Gao HB, Li D, et al. Effect of fecal bacteria transplantation combined with lactulose in the treatment of chronic functional constipation in the elderly. J Pract Med. 2019;35:2731\u20136.","journal-title":"J Pract Med"},{"key":"1001_CR119","first-page":"63","volume":"16","author":"H Jiang","year":"2019","unstructured":"Jiang H. Effects of fecal microbiota transplantation combined with lactulose on the Gastrointestinal function and quality of life in patients with intractable functional constipation. Health Med Res Prac. 2019;16:63\u20136.","journal-title":"Health Med Res Prac"},{"key":"1001_CR120","first-page":"555","volume":"29","author":"JT Ye","year":"2019","unstructured":"Ye JT. Clinical efficacy of fecal bacteria transplantation combined with lactulose in the treatment of functional constipation in the elderly and its effect on Gastrointestinal hormone. Zhejiang J Integr Traditional Chin Western Med. 2019;29:555\u20137.","journal-title":"Zhejiang J Integr Traditional Chin Western Med"},{"issue":"1","key":"1001_CR121","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12866-023-03123-1","volume":"23","author":"C Yang","year":"2023","unstructured":"Yang C, Hu T, Xue X, et al. Multi-omics analysis of fecal microbiota transplantation\u2019s impact on functional constipation and comorbid depression and anxiety. BMC Microbiol. 2023;23(1):389. https:\/\/doi.org\/10.1186\/s12866-023-03123-1. Published 2023 Dec 7.","journal-title":"BMC Microbiol"},{"key":"1001_CR122","doi-asserted-by":"publisher","first-page":"700718","DOI":"10.3389\/fmicb.2021.700718","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li N, Chen Q, Qin H. Fecal microbiota transplantation modulates the gut flora favoring patients with functional constipation. Front Microbiol. 2021;12:700718. https:\/\/doi.org\/10.3389\/fmicb.2021.700718. Published 2021 Oct 7.","journal-title":"Front Microbiol"},{"key":"1001_CR123","doi-asserted-by":"publisher","unstructured":"Lee JW, Kim N, Korean. J Gastroenterol. 2024;84(4):168\u201376. https:\/\/doi.org\/10.4166\/kjg.2024.107.","DOI":"10.4166\/kjg.2024.107"},{"key":"1001_CR124","doi-asserted-by":"publisher","unstructured":"Hamazaki M, Sawada T, Yamamura T, et al. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. BMC Gastroenterol. 2022;22(1):342. https:\/\/doi.org\/10.1186\/s12876-022-02408-5. Published 2022 Jul 14.","DOI":"10.1186\/s12876-022-02408-5"},{"key":"1001_CR125","doi-asserted-by":"publisher","unstructured":"Tian HL, Chen QY, Yang B et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(Z1):63\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn.441530-20200415-00212","DOI":"10.3760\/cma.j.cn.441530-20200415-00212"},{"key":"1001_CR126","doi-asserted-by":"publisher","unstructured":"Lin ZL, Chen QY, Tian HL et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(Z1):56\u201362. https:\/\/doi.org\/10.3760\/cma.j.cn.441530-20200414-00207","DOI":"10.3760\/cma.j.cn.441530-20200414-00207"},{"key":"1001_CR127","doi-asserted-by":"publisher","unstructured":"Li N, Tian HL, Chen QY et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2019;22(9):861\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.1671-0274.2019.09.011","DOI":"10.3760\/cma.j.issn.1671-0274.2019.09.011"},{"issue":"3","key":"1001_CR128","doi-asserted-by":"publisher","first-page":"e0214085","DOI":"10.1371\/journal.pone.0214085","volume":"14","author":"T Ohara","year":"2019","unstructured":"Ohara T. Identification of the microbial diversity after fecal microbiota transplantation therapy for chronic intractable constipation using 16s rRNA amplicon sequencing. PLoS ONE. 2019;14(3):e0214085. https:\/\/doi.org\/10.1371\/journal.pone.0214085. Published 2019 Mar 19.","journal-title":"PLoS ONE"},{"key":"1001_CR129","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jad.2018.04.038","volume":"235","author":"S Kurokawa","year":"2018","unstructured":"Kurokawa S, Kishimoto T, Mizuno S, et al. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study. J Affect Disord. 2018;235:506\u201312. https:\/\/doi.org\/10.1016\/j.jad.2018.04.038.","journal-title":"J Affect Disord"},{"issue":"7","key":"1001_CR130","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s11427-017-9229-1","volume":"61","author":"X Zhang","year":"2018","unstructured":"Zhang X, Tian H, Gu L, et al. Long-term follow-up of the effects of fecal microbiota transplantation in combination with soluble dietary fiber as a therapeutic regimen in slow transit constipation. Sci China Life Sci. 2018;61(7):779\u201386. https:\/\/doi.org\/10.1007\/s11427-017-9229-1.","journal-title":"Sci China Life Sci"},{"issue":"3","key":"1001_CR131","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.arcmed.2016.06.005","volume":"47","author":"X Ge","year":"2016","unstructured":"Ge X, Tian H, Ding C, et al. Fecal microbiota transplantation in combination with soluble dietary Fiber for treatment of slow transit constipation: A pilot study. Arch Med Res. 2016;47(3):236\u201342. https:\/\/doi.org\/10.1016\/j.arcmed.2016.06.005.","journal-title":"Arch Med Res"},{"key":"1001_CR132","unstructured":"Zhang X, Tian H, Ma C, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(12):1355\u20139."},{"issue":"11","key":"1001_CR133","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.14309\/ajg.0000000000002958","volume":"119","author":"X Gu","year":"2024","unstructured":"Gu X, Yang Z, Kou Y, et al. Effects of retrograde colonic Enema-Based fecal microbiota transplantation in the treatment of childhood constipation: A randomized, Double-Blind, controlled trial. Am J Gastroenterol. 2024;119(11):2288\u201397. https:\/\/doi.org\/10.14309\/ajg.0000000000002958.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1001_CR134","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/MCG.0000000000000472","volume":"50","author":"H Tian","year":"2016","unstructured":"Tian H, Ding C, Gong J, et al. Treatment of slow transit constipation with fecal microbiota transplantation: A pilot study. J Clin Gastroenterol. 2016;50(10):865\u201370. https:\/\/doi.org\/10.1097\/MCG.0000000000000472.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1001_CR135","doi-asserted-by":"publisher","first-page":"e056594","DOI":"10.1136\/bmjopen-2021-056594","volume":"12","author":"J Hurych","year":"2022","unstructured":"Hurych J, Vejmelka J, Hlinakova L, et al. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors. BMJ Open. 2022;12(6):e056594. https:\/\/doi.org\/10.1136\/bmjopen-2021-056594. Published 2022 Jun 27.","journal-title":"BMJ Open"},{"issue":"1","key":"1001_CR136","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12934-021-01720-1","volume":"20","author":"H Lin","year":"2021","unstructured":"Lin H, Guo Q, Wen Z, et al. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Microb Cell Fact. 2021;20(1):233. https:\/\/doi.org\/10.1186\/s12934-021-01720-1. Published 2021 Dec 28.","journal-title":"Microb Cell Fact"},{"issue":"6","key":"1001_CR137","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/00365521.2019.1624815","volume":"54","author":"T Mazzawi","year":"2019","unstructured":"Mazzawi T, Hausken T, Hov JR, et al. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. Scand J Gastroenterol. 2019;54(6):690\u20139. https:\/\/doi.org\/10.1080\/00365521.2019.1624815.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"1001_CR138","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/MPG.0000000000001476","volume":"64","author":"J Wang","year":"2017","unstructured":"Wang J, Gu J, Wang Y, et al. 16S rDNA gene sequencing analysis in functional dyspepsia treated with fecal microbiota transplantation. J Pediatr Gastroenterol Nutr. 2017;64(3):e80\u20132. https:\/\/doi.org\/10.1097\/MPG.0000000000001476.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"1001_CR139","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1177\/2050640619866990","volume":"7","author":"K Myneedu","year":"2019","unstructured":"Myneedu K, Deoker A, Schmulson MJ, Bashashati M. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and metaanalysis. United Eur Gastroenterol J. 2019;7(8):1033\u201341. https:\/\/doi.org\/10.1177\/2050640619866990.","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"1001_CR140","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.15330","volume":"50","author":"G Ianiro","year":"2019","unstructured":"Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(3):240\u20138. https:\/\/doi.org\/10.1111\/apt.15330.","journal-title":"Aliment Pharmacol Ther"},{"issue":"19","key":"1001_CR141","doi-asserted-by":"publisher","first-page":"14562","DOI":"10.3390\/ijms241914562","volume":"24","author":"P Jamshidi","year":"2023","unstructured":"Jamshidi P, Farsi Y, Nariman Z, et al. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and Meta-Analysis of randomized controlled trials. Int J Mol Sci. 2023;24(19):14562. https:\/\/doi.org\/10.3390\/ijms241914562. Published 2023 Sep 26.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1001_CR142","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12876-024-03311-x","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu Y, Shi P. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome. BMC Gastroenterol. 2024;24(1):217. https:\/\/doi.org\/10.1186\/s12876-024-03311-x. Published 2024 Jul 5.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"1001_CR143","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/jcm12051725","volume":"12","author":"T Rodrigues","year":"2023","unstructured":"Rodrigues T, Rodrigues Fialho S, Ara\u00fajo JR, Rocha R, Moreira-Ros\u00e1rio A. Procedures in fecal microbiota transplantation for treating irritable bowel syndrome: systematic review and Meta-Analysis. J Clin Med. 2023;12(5):1725. https:\/\/doi.org\/10.3390\/jcm12051725. Published 2023 Feb 21.","journal-title":"J Clin Med"},{"issue":"4","key":"1001_CR144","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","volume":"66","author":"G Cammarota","year":"2017","unstructured":"Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569\u201380. https:\/\/doi.org\/10.1136\/gutjnl-2016-313017.","journal-title":"Gut"},{"issue":"2","key":"1001_CR145","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1574-6968.2012.02523.x","volume":"329","author":"MI Bahl","year":"2012","unstructured":"Bahl MI, Bergstr\u00f6m A, Licht TR. Freezing fecal samples prior to DNA extraction affects the Firmicutes to Bacteroidetes ratio determined by downstream quantitative PCR analysis. FEMS Microbiol Lett. 2012;329(2):193\u20137. https:\/\/doi.org\/10.1111\/j.1574-6968.2012.02523.x.","journal-title":"FEMS Microbiol Lett"},{"key":"1001_CR146","unstructured":"European Directorate for the Quality of Medicines & HealthCare Guide to the Quality and Safety of Tissues and Cells for Human Application. 4th ed. 2019. [(accessed on 1 March 2025)]. Available online: https:\/\/www.edqm.eu\/en\/guide-to-the-quality-and-safety-of-tissues-and-cells-for-human-application1"},{"key":"1001_CR147","doi-asserted-by":"publisher","first-page":"827395","DOI":"10.3389\/fcimb.2022.827395","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Lv L, Wang C. Efficacy of fecal microbiota transplantation in irritable bowel syndrome: A Meta-Analysis of randomized controlled trials. Front Cell Infect Microbiol. 2022;12:827395. https:\/\/doi.org\/10.3389\/fcimb.2022.827395. Published 2022 Feb 28.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"1001_CR148","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","volume":"70","author":"DH Vasant","year":"2021","unstructured":"Vasant DH, Paine PA, Black CJ, et al. British society of gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214\u201340. https:\/\/doi.org\/10.1136\/gutjnl-2021-324598.","journal-title":"Gut"},{"issue":"14","key":"1001_CR149","doi-asserted-by":"publisher","first-page":"e25390","DOI":"10.1097\/MD.0000000000025390","volume":"100","author":"S Fang","year":"2021","unstructured":"Fang S, Wu S, Ji L, Fan Y, Wang X, Yang K. The combined therapy of fecal microbiota transplantation and laxatives for functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Med (Baltim). 2021;100(14):e25390. https:\/\/doi.org\/10.1097\/MD.0000000000025390.","journal-title":"Med (Baltim)"},{"key":"1001_CR150","doi-asserted-by":"publisher","unstructured":"Tian Y, Zuo L, Guo Q et al. Potential role of fecal microbiota in patients with constipation. Therap Adv Gastroenterol. 2020;13:1756284820968423. Published 2020 Oct 31. https:\/\/doi.org\/10.1177\/1756284820968423","DOI":"10.1177\/1756284820968423"},{"issue":"8","key":"1001_CR151","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MCG.0000000000001281","volume":"54","author":"BK Perler","year":"2020","unstructured":"Perler BK, Chen B, Phelps E, et al. Long-Term efficacy and safety of fecal microbiota transplantation for treatment of recurrent clostridioides difficile infection. J Clin Gastroenterol. 2020;54(8):701\u20136. https:\/\/doi.org\/10.1097\/MCG.0000000000001281.","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"1001_CR152","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10096-019-03602-2","volume":"38","author":"CH Lee","year":"2019","unstructured":"Lee CH, Chai J, Hammond K, et al. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory clostridioides difficile infection with or without antibiotic exposure. Eur J Clin Microbiol Infect Dis. 2019;38(9):1731\u20135. https:\/\/doi.org\/10.1007\/s10096-019-03602-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1001_CR153","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1053\/j.gastro.2017.01.028","volume":"152","author":"CR Kelly","year":"2017","unstructured":"Kelly CR, Kim AM, Laine L, Wu GD. The aga\u2019s fecal microbiota transplantation National registry: an important step toward Understanding risks and benefits of microbiota therapeutics. Gastroenterology. 2017;152(4):681\u20134. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.028.","journal-title":"Gastroenterology"},{"issue":"5","key":"1001_CR154","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/antibiotics13050436","volume":"13","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hunt A, Danziger L, Drwiega EN. A comparison of currently available and investigational fecal microbiota transplant products for recurrent clostridioides difficile infection. Antibiot (Basel). 2024;13(5):436. https:\/\/doi.org\/10.3390\/antibiotics13050436. Published 2024 May 12.","journal-title":"Antibiot (Basel)"},{"issue":"9","key":"1001_CR155","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41579-018-0024-1","volume":"16","author":"S Banerjee","year":"2018","unstructured":"Banerjee S, Schlaeppi K, van der Heijden MGA. Keystone taxa as drivers of Microbiome structure and functioning. Nat Rev Microbiol. 2018;16(9):567\u201376. https:\/\/doi.org\/10.1038\/s41579-018-0024-1.","journal-title":"Nat Rev Microbiol"},{"key":"1001_CR156","doi-asserted-by":"publisher","first-page":"784797","DOI":"10.3389\/fmicb.2021.784797","volume":"12","author":"OFA Larsen","year":"2021","unstructured":"Larsen OFA, van de Burgwal LHM. On the verge of a catastrophic collapse?? The need for a Multi-Ecosystem approach to Microbiome studies. Front Microbiol. 2021;12:784797. https:\/\/doi.org\/10.3389\/fmicb.2021.784797. Published 2021 Dec 2.","journal-title":"Front Microbiol"},{"key":"1001_CR157","doi-asserted-by":"publisher","unstructured":"Chibani CM, Mahnert A, Borrel G et al. A catalogue of 1,167 genomes from the human gut archaeome [published correction appears in Nat Microbiol. 2022;7(2):339. doi: 10.1038\/s41564-022-01061-8.]. Nat Microbiol. 2022;7(1):48\u201361. https:\/\/doi.org\/10.1038\/s41564-021-01020-9","DOI":"10.1038\/s41564-021-01020-9"},{"key":"1001_CR158","doi-asserted-by":"publisher","unstructured":"Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy [published correction appears in Front Microbiol. 2019;10:1870. https:\/\/doi.org\/10.3389\/fmicb.2019.01870.]. Front Microbiol. 2019;10:1136. Published 2019 Jun 10. doi:10.3389\/fmicb.2019.01136.","DOI":"10.3389\/fmicb.2019.01870.]"},{"key":"1001_CR159","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3389\/fmicb.2019.01894","volume":"10","author":"Y Gu","year":"2019","unstructured":"Gu Y, Zhou G, Qin X, Huang S, Wang B, Cao H. The potential role of gut mycobiome in irritable bowel syndrome. Front Microbiol. 2019;10:1894. https:\/\/doi.org\/10.3389\/fmicb.2019.01894. Published 2019 Aug 21.","journal-title":"Front Microbiol"},{"key":"1001_CR160","doi-asserted-by":"publisher","first-page":"175628482210915","DOI":"10.1177\/17562848221091524","volume":"15","author":"G Ianiro","year":"2022","unstructured":"Ianiro G, Iorio A, Porcari S, et al. How the gut parasitome affects human health. Th Adv Gastroenterol. 2022;15:17562848221091524. https:\/\/doi.org\/10.1177\/17562848221091524. Published 2022 Apr 30.","journal-title":"Th Adv Gastroenterol"},{"issue":"12","key":"1001_CR161","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1080\/00365521.2020.1839544","volume":"55","author":"S Holster","year":"2020","unstructured":"Holster S, Rode J, Bohr J, et al. Faecal microbiota transfer in patients with microscopic colitis - a pilot study in collagenous colitis. Scand J Gastroenterol. 2020;55(12):1454\u201366. https:\/\/doi.org\/10.1080\/00365521.2020.1839544.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1001_CR162","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1264\/jsme2.ME17017","volume":"32","author":"ET Hillman","year":"2017","unstructured":"Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the Gastrointestinal tract. Microbes Environ. 2017;32(4):300\u201313. https:\/\/doi.org\/10.1264\/jsme2.ME17017.","journal-title":"Microbes Environ"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-01001-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:03:04Z","timestamp":1772578984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-01001-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-01001-6","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"30 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the Declaration of Helsinki 1964 and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Human Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Taha Bin Arif: NoneJohn A Damianos: Clinical trial funding and consulting fees from ExeGi Pharma; Speaker\u2019s bureau fees from i-Health.Asad-Ur-Rahman: Speaker\u2019s bureau fees from AbbVieNimra Hasnain: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"50"}}